Drug Approvals
🇺🇸 FDA Page 36FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global drug approvals & regulatory decisions. Gain critical intelligence on new therapies, market access, and competitive landscapes for pharma BD.
Showing 421–432 of 665 articles
From Reach to Relevance: Transforming Pharma Marketing Strategies
AstraZeneca Secures FDA Approval for Hypertension Drug
Regeneron's Phase 3 Skin Cancer Miss: Implications for LAG-3 Development
Trump's CMS Expands Catastrophic Coverage on ACA Exchanges
Why the WakeMed – Atrium Health Merger Matters for Pharma
FDA Approves Atezolizumab for Muscle-Invasive Bladder Cancer
M&A in Pharmaceuticals: Bigger, Bolder, and Far More Strategic
Enhertu's Dual FDA Approvals: A Game Changer in Early Breast Cancer Treatment
The Future of AI in Pharma Marketing
Navigating the New Policy Landscape in Pharma
Wegovy Pill Scripts Decline: Implications for Pharma
The Cloudy Truth About Blue Zones: Insights for Pharma